Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction

Standard

Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction. / Reeh, M; Mina, S; Bockhorn, M; Kutup, A; Nentwich, M F; Marx, A; Sauter, G; Rösch, T; Izbicki, J R; Bogoevski, D.

in: BRIT J SURG, Jahrgang 99, Nr. 10, 01.10.2012, S. 1406-14.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{ae33b732d6ad44a18bcf7ace5bcc7e64,
title = "Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction",
abstract = "BACKGROUND: Owing to controversial staging and classification of adenocarcinoma of the oesophago-gastric junction (AOG) before surgery, the choice of appropriate surgical approach remains problematic. In a retrospective study, preoperative staging of AOG and the impact of preoperative misclassification on outcome were analysed.METHODS: Data from patients with AOG were analysed from a prospectively collected database with regard to surgical treatment, preoperative and postoperative staging, and outcome.RESULTS: One-hundred and thirty patients with Siewert types I and II AOG who did not have neoadjuvant treatment were included in the study: 41 patients with an AOG type I who underwent oesophagectomy, 51 patients with an AOG staged before surgery as type I who underwent oesophagectomy but in whom the final histology showed a type II tumour, and 38 patients whose tumours were staged as AOG type II before and after operation who underwent gastrectomy. Among patients who had an oesophagectomy, lymph node metastases (P = 0.022), tumour relapse (P = 0.009) and recurrent distant metastases (P = 0.028) were significantly more frequent in patients with AOG type II; those with AOG type II had shorter overall survival than those with type I tumours (P = 0.024). Among those with AOG type II, recurrence-free survival was significantly shorter after oesophagectomy compared with extended gastrectomy (P = 0.019). Thoracoabdominal oesophagectomy had a favourable influence on outcome compared with the transhiatal approach.CONCLUSION: Accurate preoperative staging of AOG and appropriate surgical therapy are crucial for outcome. AOG type II is a more aggressive tumour with higher recurrence rates than AOG type I. These patients therefore benefit from more radical surgical treatment.",
keywords = "Adenocarcinoma, Adult, Aged, Esophageal Neoplasms, Esophagectomy, Esophagogastric Junction, Female, Gastrectomy, Humans, Intraoperative Care, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Preoperative Care, Retrospective Studies, Stomach Neoplasms",
author = "M Reeh and S Mina and M Bockhorn and A Kutup and Nentwich, {M F} and A Marx and G Sauter and T R{\"o}sch and Izbicki, {J R} and D Bogoevski",
note = "Copyright {\textcopyright} 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.",
year = "2012",
month = oct,
day = "1",
doi = "10.1002/bjs.8884",
language = "English",
volume = "99",
pages = "1406--14",
journal = "BRIT J SURG",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

RIS

TY - JOUR

T1 - Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction

AU - Reeh, M

AU - Mina, S

AU - Bockhorn, M

AU - Kutup, A

AU - Nentwich, M F

AU - Marx, A

AU - Sauter, G

AU - Rösch, T

AU - Izbicki, J R

AU - Bogoevski, D

N1 - Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BACKGROUND: Owing to controversial staging and classification of adenocarcinoma of the oesophago-gastric junction (AOG) before surgery, the choice of appropriate surgical approach remains problematic. In a retrospective study, preoperative staging of AOG and the impact of preoperative misclassification on outcome were analysed.METHODS: Data from patients with AOG were analysed from a prospectively collected database with regard to surgical treatment, preoperative and postoperative staging, and outcome.RESULTS: One-hundred and thirty patients with Siewert types I and II AOG who did not have neoadjuvant treatment were included in the study: 41 patients with an AOG type I who underwent oesophagectomy, 51 patients with an AOG staged before surgery as type I who underwent oesophagectomy but in whom the final histology showed a type II tumour, and 38 patients whose tumours were staged as AOG type II before and after operation who underwent gastrectomy. Among patients who had an oesophagectomy, lymph node metastases (P = 0.022), tumour relapse (P = 0.009) and recurrent distant metastases (P = 0.028) were significantly more frequent in patients with AOG type II; those with AOG type II had shorter overall survival than those with type I tumours (P = 0.024). Among those with AOG type II, recurrence-free survival was significantly shorter after oesophagectomy compared with extended gastrectomy (P = 0.019). Thoracoabdominal oesophagectomy had a favourable influence on outcome compared with the transhiatal approach.CONCLUSION: Accurate preoperative staging of AOG and appropriate surgical therapy are crucial for outcome. AOG type II is a more aggressive tumour with higher recurrence rates than AOG type I. These patients therefore benefit from more radical surgical treatment.

AB - BACKGROUND: Owing to controversial staging and classification of adenocarcinoma of the oesophago-gastric junction (AOG) before surgery, the choice of appropriate surgical approach remains problematic. In a retrospective study, preoperative staging of AOG and the impact of preoperative misclassification on outcome were analysed.METHODS: Data from patients with AOG were analysed from a prospectively collected database with regard to surgical treatment, preoperative and postoperative staging, and outcome.RESULTS: One-hundred and thirty patients with Siewert types I and II AOG who did not have neoadjuvant treatment were included in the study: 41 patients with an AOG type I who underwent oesophagectomy, 51 patients with an AOG staged before surgery as type I who underwent oesophagectomy but in whom the final histology showed a type II tumour, and 38 patients whose tumours were staged as AOG type II before and after operation who underwent gastrectomy. Among patients who had an oesophagectomy, lymph node metastases (P = 0.022), tumour relapse (P = 0.009) and recurrent distant metastases (P = 0.028) were significantly more frequent in patients with AOG type II; those with AOG type II had shorter overall survival than those with type I tumours (P = 0.024). Among those with AOG type II, recurrence-free survival was significantly shorter after oesophagectomy compared with extended gastrectomy (P = 0.019). Thoracoabdominal oesophagectomy had a favourable influence on outcome compared with the transhiatal approach.CONCLUSION: Accurate preoperative staging of AOG and appropriate surgical therapy are crucial for outcome. AOG type II is a more aggressive tumour with higher recurrence rates than AOG type I. These patients therefore benefit from more radical surgical treatment.

KW - Adenocarcinoma

KW - Adult

KW - Aged

KW - Esophageal Neoplasms

KW - Esophagectomy

KW - Esophagogastric Junction

KW - Female

KW - Gastrectomy

KW - Humans

KW - Intraoperative Care

KW - Kaplan-Meier Estimate

KW - Lymphatic Metastasis

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Preoperative Care

KW - Retrospective Studies

KW - Stomach Neoplasms

U2 - 10.1002/bjs.8884

DO - 10.1002/bjs.8884

M3 - SCORING: Journal article

C2 - 22961520

VL - 99

SP - 1406

EP - 1414

JO - BRIT J SURG

JF - BRIT J SURG

SN - 0007-1323

IS - 10

ER -